Politics
Bayer reaches Roundup settlement that could cost the company billions
NPR News·November 21, 2026·1 min read
Bayer reached a Roundup settlement that could cost the company billions. The money will go to thousands of people who have been or will be diagnosed with non-Hodgkin lymphoma, a blood cancer linked to the herbicide. The settlement addresses claims from individuals affected by the weedkiller's alleged health risks.
Read at NPR NewsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.